CD22-directed Immunoconjugate [EPC]
1 drugs in this class with 10,115 total adverse event reports.
1 Drugs
10,115 Total Reports
5,954 Serious Reports
1,854 Death Reports
| # | Drug Name | Generic Name | Reports | Serious | Deaths |
|---|---|---|---|---|---|
| 1 | Blinatumomab | BLINATUMOMAB | 10,115 | 5,954 | 1,854 |